Mangoceuticals, Inc.MGRXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank25
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-5.90M
↓ 54% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-3.83M
Historical baseline
PeriodValueYoY Change
TTM$-5.90M-21.3%
2024$-4.86M+30.5%
2023$-7.00M-403.8%
2022$-1.39M-7831.6%
2021$-17520.00-